1st Quarter - Report

RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: S. 637 (115th), S. 771 (115th)

Health Issues HCR

S. Con. Res. 3 - Budget Resolution for FY2017 - Impact of reconciliation instructions on the prescription drug benefit and coverage for those covered through health care market places and Medicaid beneficiaries. S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 3 (115th), S. 771 (115th), S. 637 (115th)

Pharmacy PHA

S. Con. Res. 3 - Budget Resolution for FY2017 - Impact of reconciliation instructions on the prescription drug benefit and coverage for those covered through health care market places and Medicaid beneficiaries. S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 771 (115th), S. 637 (115th), S.Con.Res. 3 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.